Author:
Attia Yasmeen M.,El-Kersh Dina M.,Wagdy Hebatallah A.,Elmazar Mohamed M.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Torre, L. A. et al. Global cancer statistics, 2012. CA. Cancer J. Clin. 65, 87–108 (2015).
2. Ekbom, A., Helmick, C., Zack, M. & Adami, H. O. Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med. 323, 1228–1233 (1990).
3. Eaden, J. A., Abrams, K. R. & Mayberry, J. F. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48, 526–535 (2001).
4. Willenbucher, R. F., Zelman, S. J., Ferrell, L. D., Moore, D. H. & Waldman, F. M. Chromosomal alterations in ulcerative colitis-related neoplastic progression. Gastroenterology 113, 791–801 (1997).
5. Porta, C., Paglino, C. & Mosca, A. Targeting PI3K/Akt/mTOR Signaling in Cancer. Front. Oncol. 14, 4–64 (2014).